• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MPP

METRO PERFORMANCE GLASS LIMITED - Charts / Financials

0.00% ! 6.6¢
Market Cap $12.23M  !
Consumer Cyclical Home Furnishings & Fixtures
Add to My Watchlist
refresh Created with Sketch. REFRESH
Last update - 10.00am 26/06/2025 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   1 6.6¢ 5871

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.23M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Top Stories

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

What do you get when Neometals (ASX:NMT), joined by Mineral Resources (ASX:MIN), and Rio Tinto (ASX:RIO) walk into a room?
Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 26 epis...
Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up Paradigm Biopharmaceuticals (ASX:PAR) has acquired the exclusive global rights to develop @ and, of course, commercialise @ a novel oral combination of PPS and a COX-2 inhibitor designed to treat osteoarthritis and pains.Listen to the HotCopper podcast for in-depth discussions and insights on all...
Australia’s gas crisis is here – and dying coal plants aren’t helping  The east coast of Australia is facing a looming gas shortage crisis. Just last week, the Australian state of Victoria...
Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment Neuren Pharma (ASX:NEU) has seen its shares jump over +11% as the company wins a patent to treat Pitt Hopkins Syndrome...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.